IFNB1 and melanoma: On the other hand, in melanoma, intratumoral injection of IFN-β induces expression of CCL5 and CXCR3 ligands and administration of IFN-β with anti-PD-1 monoclonal antibodies suppressed the tumor growth and prolonged the survival in a murine model36.